Galantamine vs donepezil in the treatment of Alzheimer's disease.

Galantamine vs donepezil in the treatment of Alzheimer's disease.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Goldlist, B, Gordon, M, Naglie, G
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2003

Παρόμοια τεκμήρια

A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
ανά: Wilcock, G, κ.ά.
Έκδοση: (2003)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
ανά: Wilcock, G, κ.ά.
Έκδοση: (2003)

Galantamine in Alzheimer's disease.
ανά: Razay, G, κ.ά.
Έκδοση: (2008)

Donepezil for the treatment of agitation in Alzheimer's disease.
ανά: Howard, R, κ.ά.
Έκδοση: (2007)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
ανά: Sano, M, κ.ά.
Έκδοση: (2003)

Donepezil for dementia due to Alzheimer's disease
ανά: Birks, J, κ.ά.
Έκδοση: (2018)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
ανά: Howard, R, κ.ά.
Έκδοση: (2012)

The beneficial effects of galantamine on caregiver time in Alzheimer's disease
ανά: Sano, M, κ.ά.
Έκδοση: (2003)

Design and development of galantamine hydrobromide transdermal patch for treatment of alzheimer’s disease
ανά: Woo, Fong Yen
Έκδοση: (2015)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
ανά: Howard, R, κ.ά.
Έκδοση: (2012)

Peran donepezil dalam terapi penyakit alzheimer
ανά: Perpustakaan UGM, i-lib
Έκδοση: (1999)

Donepezil enhances frontal functional connectivity in Alzheimer's Disease: a pilot study
ανά: Griffanti, L, κ.ά.
Έκδοση: (2016)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
ανά: Wilcock, G, κ.ά.
Έκδοση: (2000)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
ανά: Pirttilä, T, κ.ά.
Έκδοση: (2004)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
ανά: Jones, R, κ.ά.
Έκδοση: (2009)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
ανά: Perdomo, C, κ.ά.
Έκδοση: (2003)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
ανά: Pratt, R, κ.ά.
Έκδοση: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
ανά: Wilcock, G, κ.ά.
Έκδοση: (2001)

Three-year follow-up of galantamine therapy for Alzheimer's disease: Efficacy and tolerability in open-label extension studies
ανά: Wilcock, G, κ.ά.
Έκδοση: (2002)

Personalized prediction of Alzheimer's disease and its treatment effects by donepezil: an individual participant data meta-analysis of eight randomized controlled trials
ανά: Yoshida, K, κ.ά.
Έκδοση: (2022)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
ανά: Whitehead, A, κ.ά.
Έκδοση: (2004)

Donepezil for vascular cognitive impairment
ανά: Malouf, R, κ.ά.
Έκδοση: (2004)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
ανά: Wilcock, G
Έκδοση: (2001)

Patterns of clinically detectable treatment effects with galantamine: a qualitative analysis.
ανά: Joffres, C, κ.ά.
Έκδοση: (2003)

Early- and subsequent- response of cognitive functioning in Alzheimer's disease: Individual-participant data from five pivotal randomized clinical trials of donepezil
ανά: Levine, SZ, κ.ά.
Έκδοση: (2022)

Effect of galantamine on time to residential or nursing home admission
ανά: Feldman, H, κ.ά.
Έκδοση: (2004)

Treatment for Alzheimer's disease.
ανά: Wilcock, G
Έκδοση: (2000)

Safety and efficacy of galantamine in subjects with mild cognitive impairment.
ανά: Winblad, B, κ.ά.
Έκδοση: (2008)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
ανά: Wilcock, G
Έκδοση: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
ανά: Wilcock, G
Έκδοση: (2001)

Quantifying the heterogeneity of cognitive functioning in Alzheimer’s disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil
ανά: Levine, SG, κ.ά.
Έκδοση: (2021)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
ανά: Wilcock, G, κ.ά.
Έκδοση: (1993)

Perspectives of Alzheimer's disease treatments.
ανά: Davis, J, κ.ά.
Έκδοση: (2008)

Clioquinol for the treatment of Alzheimer's Disease.
ανά: Jenagaratnam, L, κ.ά.
Έκδοση: (2006)

Current approaches to the treatment of Alzheimer's disease.
ανά: Wilcock, G
Έκδοση: (1996)

Treatment of the cholinergic impairment in Alzheimer's disease
ανά: Wilcock, G
Έκδοση: (1994)

Treatment of Alzheimer's disease: future directions.
ανά: Wilcock, G, κ.ά.
Έκδοση: (1996)

Issues in drug treatment for Alzheimer's disease.
ανά: Mcshane, R, κ.ά.
Έκδοση: (1997)

Formulation and evaluation of galantamine gel as drug reservoir in transdermal patch delivery system
ανά: Woo, Fong Yen, κ.ά.
Έκδοση: (2015)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
ανά: Wilcock, G
Έκδοση: (2007)